LncRNA MALAT-1 was also detected in significantly higher quantities in the plasma of patients with prostate cancer as compared to healthy subjects26 and these changes in circulating MALAT-1 levels correlated with prostate cancer with relatively high specificity (84.8%)26. Here, MALAT1 is linked to prostate carcinoma.